CHD | Connected Health Development

Get Started

Connected Health Development

Connected Health Development

CHD (Connected Health Development), founded in 2018, is a Medtech company and eHealth Service Operator operating in Europe.

Discover ↓

Vision & Mission

CHD’s mission is to:

01.

Develop, launch and operate innovative digital health and wellness solutions to improve patient assessment, diagnosis and monitoring, in real-world or immersive environments.

02.

Enable healthcare professionals to access reliable, high-performance and user-friendly tools for measurement, analysis and clinical decision-making.

The use and integration by CHD of the latest proven technologies – whether sensors, immersive solutions or digital platforms integrating advanced algorithms – enable healthcare professionals to access precise and relevant indicators for clinical assessment and therapeutic guidance.

CHD thus puts connected health at the service of the greatest number and for the benefit of patients’ quality of life.

Our connected health solutions, developed and distributed by us or offered on a white-label basis for third parties (Pharmaceutical Groups, Medtech, etc.), are all scientifically validated.

CHD introduces a new neuroscience offering and innovation: Nesplora.

01.

Develop, launch and operate innovative digital health solutions to improve patient assessment, diagnosis and monitoring, in real-world or immersive environments.

02.

Enable healthcare professionals to access reliable, high-performance and user-friendly tools for measurement, analysis and clinical decision-making.

The use and integration by CHD of the latest proven technologies – whether sensors, immersive solutions or digital platforms integrating advanced algorithms – enable healthcare professionals to access precise and relevant indicators for clinical assessment and therapeutic guidance.

CHD thus puts connected health at the service of the greatest number and for the benefit of patients’ quality of life.

Our connected health solutions, developed and operated by us or in white-label for third parties (Pharmaceutical Groups, Medtech, etc.), are all health certified (CE IIa).

CHD introduces a new initiative: Nesplora.

sessions of

20-30

minutes

sessions of

20-30

minutes

Nesplora: Assessment of cognitive functions

Nesplora, an innovative solution based on Virtual Reality to test and assess cognitive functions.

Nesplora measures attention, impulsivity, motor activity and executive functions in children and adults through 20 to 30-minute sessions that automatically generate a highly detailed report.

Nesplora: Report generation and support

These automatically generated reports, made available to the healthcare professional, caregiver and/or application user, cover performance, gaps or difficulties identified in specific cognitive functions during testing, enabling a precise diagnosis, the implementation of a support program, or the initiation of therapy with a healthcare professional.

Nesplora: Access and distribution

More than 1,000 healthcare professionals (psychologists, neurologists and speech-language pathologists) across the Americas have adopted Nesplora to assess the cognitive functions of over 100,000 patients in the past three years.

CHD ensures its distribution and commercialization in French-speaking countries, with a dedicated version available in French.

Access our Nesplora brochure in French by clicking here.

How to purchase Nesplora? Select the package that best suits your practice.

How to use Nesplora:
• Download the application
• Create your account on the Nesplora platform

Contact CHD: For personalized support in French-speaking countries, contact CHD.

The team

CEO: Laurent Vandebrouck

CEO: Laurent Vandebrouck

Entrepreneur specializing in the development, launch, scaling, and operation of digital health solutions and services across Europe and the U.S. Former Managing Director Europe at Qualcomm Life (6 years, USA), CEO of Chronolife (5 years, France), CEO of Restorative NeuroTechnologies (2.5 years, Italy), and CEO of CHD since 2018.

COO & QARA: Dr. Giusy Fiucci

COO & QARA: Dr. Giusy Fiucci

Senior executive with recognized expertise in clinical and regulatory affairs, bringing over 20 years of international experience across biotechnology, medical devices, and digital health. Led global scientific and regulatory programs for innovative medical technologies, including connected medical devices and combined pharma–health solutions, supporting partnerships and market access.

CSO: Dr. Marc Salomon

CSO: Dr. Marc Salomon

Cardiologist and intensive care specialist, expert in preventive medicine and digital health entrepreneurship.Medical and Scientific Director for several French digital health startups and organizations. Co-founder of Figaro Santé.fr and active member of multiple healthcare Think Tanks in France. Expert in digital health platforms and the development and certification of new health indicators.

CTO: Fernando Romao

CTO: Fernando Romao

Expert in technical and industrial management of medical devices. Graduate of CentraleSupélec and ENSAM. Former VP Engineering at Chronolife, CTO at Octonion, Head of Development at Archos, and R&D Unit Director at Safran. Expertise in embedded and mobile software, AI, signal processing, and RF systems. Led the certification and industrialization of Chronolife’s connected T-shirt. Author of over 70 patents.

CEO: Laurent Vandebrouck

CEO: Laurent Vandebrouck

Entrepreneur specializing in the development, launch, scaling, and operation of digital health solutions and services across Europe and the U.S. Former Managing Director Europe at Qualcomm Life (6 years, USA), CEO of Chronolife (5 years, France), CEO of Restorative NeuroTechnologies (2.5 years, Italy), and CEO of CHD since 2018.

COO & QARA: Dr Giusy Fiucci

COO & QARA: Dr Giusy Fiucci

Senior executive with recognized expertise in clinical and regulatory affairs, bringing over 20 years of international experience across biotechnology, medical devices, and digital health. Led global scientific and regulatory programs for innovative medical technologies, including connected medical devices and combined pharma–health solutions, supporting partnerships and market access.

CSO: Dr Marc Salomon

CSO: Dr Marc Salomon

Cardiologist and intensive care specialist, expert in preventive medicine and digital health entrepreneurship.Medical and Scientific Director for several French digital health startups and organizations. Co-founder of Figaro Santé.fr and active member of multiple healthcare Think Tanks in France. Expert in digital health platforms and the development and certification of new health indicators.

CTO: Fernando Romao

CTO: Fernando Romao

Expert in technical and industrial management of medical devices. Graduate of CentraleSupélec and ENSAM. Former VP Engineering at Chronolife, CTO at Octonion, Head of Development at Archos, and R&D Unit Director at Safran. Expertise in embedded and mobile software, AI, signal processing, and RF systems. Led the certification and industrialization of Chronolife’s connected T-shirt. Author of over 70 patents.

Contact

For more information: contact@chdev.fr